Through gene-based testing we identify many canonical CH driver genes, non-canonical drivers (e.g., CHEK2), and new genes that are otherwise unlinked to CH (e.g., NEMF, KCNIP3). The gene discussed is CHEK2; the disease is cyclic hematopoiesis.